Pathcare Labs Pvt. Ltd.
Regional Laboratory - H.No-105-A , Motia Talab Road,
Near Dr.Gurdeep singh eye clinic ,Opp-Tazul Masjid,
Bhopal,462001
Ph:- 07554919504
Patient Name : Mrs. PRIYA SAHU Reg. No. : 00462305050057
Age and Sex : 34 Yrs / Female PCC Code : PCL-MP-510
Referring Doctor : NA Sample Drawn Date : 05-May-2023 12:14 PM
Referring Customer : PARI COLLECTION Registration Date : 05-May-2023 01:35 PM
Vial ID : L2741439 Report Date : 05-May-2023 03:46 PM
Sample Type : Plasma-Sodium Fluoride-Random Report Status : Final Report
Client Address : Near Om Hospital ,New Subhash Nagar, Bhopal
CLINICAL BIOCHEMISTRY
ANTE NATEL PROFILE RAPID
Test Name Obtained Value Units Bio. Ref. Intervals Method
(Age/Gender specific)
*Glucose - Blood - Random 90 mg/dL Diabetic >=200 GOD-POD
Comments:
Glucose is the major carbohydrate present in blood. Its oxidation in the cells is the source of energy for the body. Increased levels of Glucose are found in
Diabetes Mellitus, Hyperparathyroidism, Pancreatitis and renal failure.
Decreased levels are found in Insulinoma, Hypothyroidism, Hypopituitarism and extensive Liver disease.
Biological Reference Interval : Source : American Diabetic Association, Diabetes Care 2018:41 (Suppl.1) S13-S27.
*** End Of Report ***
Page 1 of 8
Note: If the test results are alarming or unexpected,Client is advised to contact the laboratory immediately for possible remedial action.
Pathcare Labs Pvt. Ltd.
Regional Laboratory - H.No-105-A , Motia Talab Road,
Near Dr.Gurdeep singh eye clinic ,Opp-Tazul Masjid,
Bhopal,462001
Ph:- 07554919504
Patient Name : Mrs. PRIYA SAHU Reg. No. : 00462305050057
Age and Sex : 34 Yrs / Female PCC Code : PCL-MP-510
Referring Doctor : NA Sample Drawn Date : 05-May-2023 12:14 PM
Referring Customer : PARI COLLECTION Registration Date : 05-May-2023 01:35 PM
Vial ID : L2741440 Report Date : 05-May-2023 02:43 PM
Sample Type : Serum Report Status : Final Report
Client Address : Near Om Hospital ,New Subhash Nagar, Bhopal
CLINICAL BIOCHEMISTRY
Test Name Obtained Value Units Bio. Ref. Intervals Method
(Age/Gender specific)
Thyroid Profile I
Tri-Iodothyronine Total (TT3) 144.70 ng/dL 70-204 CMIA
Thyroxine - Total (TT4) 7.67 µg/dL 5.5-11.0 CMIA
Thyroid Stimulating Hormone (TSH) 1.48 µIU/mL 0.4-4.2(Test performed on 4th CMIA
Generation TSH kit)
Pregnancy
TSH(μlU/mL) TT3(ng/dL) TT4(µg/dL)
1 Trimester 0.10-2.50 89.9-196.6 4.4-11.5
2 Trimester 0.2-3.00 86.1-217.4 4.9-12.2
3 Trimester 0.3-3.00 79.9-186 5.1-13.2
Interpretation:
Assay results should be interpreted in context to the clinical condition and associated results of other investigations.
Previous treatment with corticosteroid therapy may result in lower TSH levels while Thyroid hormone levels are normal.
Results are invalidated if the client has undergone a radionuclide scan within 7-14 days before the test.
Abnormal thyroid test findings often found in critically ill clients should be repeated after the critical nature of the condition is resolved.
The production, circulation, and disposal of Thyroid hormone are altered throughout the stages of pregnancy.
Hyperthyroidism (overactive thyroid):
Hyperthyroidism (overactive Thyroid) occurs when your thyroid gland produces too much of the hormone Thyroxine. Hyperthyroidism can accelerate your bodys
metabolism, causing unintentional weight loss and a rapid or irregular heartbeat.
Hypothyroidism (underactive thyroid):
Hypothyroidism (underactive thyroid) is a condition in which your Thyroid gland doesnt produce enough of certain crucial hormones. Hypothyroidism may not
cause noticeable symptoms in the early stages. Over time, untreated Hypothyroidism can cause a number of health problems, such as obesity, joint pain,
infertility and heart disease.
Page 2 of 8
Note: If the test results are alarming or unexpected,Client is advised to contact the laboratory immediately for possible remedial action.
Pathcare Labs Pvt. Ltd.
Regional Laboratory - H.No-105-A , Motia Talab Road,
Near Dr.Gurdeep singh eye clinic ,Opp-Tazul Masjid,
Bhopal,462001
Ph:- 07554919504
Patient Name : Mrs. PRIYA SAHU Reg. No. : 00462305050057
Age and Sex : 34 Yrs / Female PCC Code : PCL-MP-510
Referring Doctor : NA Sample Drawn Date : 05-May-2023 12:14 PM
Referring Customer : PARI COLLECTION Registration Date : 06-May-2023 05:09 PM
Vial ID : L3989604 Report Date : 06-May-2023 06:21 PM
Sample Type : Urine Report Status : Final Report
Client Address : Near Om Hospital ,New Subhash Nagar, Bhopal
CLINICAL PATHOLOGY
ANTE NATEL PROFILE RAPID
Test Name Obtained Value Units Bio. Ref. Intervals Method
(Age/Gender specific)
Complete Urine Analysis (CUE)
PHYSICAL EXAMINATION
Colour Pale Yellow - Straw to light amber Visual
Examination
Appearence Shazy - Clear Visual
Examination
CHEMICAL EXAMINATION
Glucose Negative Negative Reagent Strip
Reflectance
Protein Negative - Negative Reagent Strip
Reflectance
Bilirubin (Bile) Negative - Negative Reagent Strip
Reflectance
Ketone Bodies Negative Negative Reagent Strip
Reflectance
Specific gravity 1.020 1.001 - 1.035 Reagent Strip
Reflectance
Blood Negative Negative Reagent Strip
Reflectance
Reaction (pH) Acidic 4.6 - 8.0 Reagent Strip
Reflectance
Nitrites Negative Negative Reagent Strip
Reflectance
Leukocytes Negative Negative Reagent Strip
Reflectance
MICROSCOPIC EXAMINATION
PUS(WBC) Cells 2-3 /hpf 00-05 Microscopy
Red Blood Cells Absent /hpf Absent Microscopy
U.Epithelial Cells 4-5 /hpf 00-05 Microscopy
Casts Absent /hpf Occasional Hyaline cast Microscopy
Crystals Absent /hpf Absent Microscopy
Others Absent /hpf Absent Microscopy
Page 3 of 8
Note: If the test results are alarming or unexpected,Client is advised to contact the laboratory immediately for possible remedial action.
Pathcare Labs Pvt. Ltd.
Regional Laboratory - H.No-105-A , Motia Talab Road,
Near Dr.Gurdeep singh eye clinic ,Opp-Tazul Masjid,
Bhopal,462001
Ph:- 07554919504
Patient Name : Mrs. PRIYA SAHU Reg. No. : 00462305050057
Age and Sex : 34 Yrs / Female PCC Code : PCL-MP-510
Referring Doctor : NA Sample Drawn Date : 05-May-2023 12:14 PM
Referring Customer : PARI COLLECTION Registration Date : 05-May-2023 01:35 PM
Vial ID : L2741442 Report Date : 05-May-2023 02:59 PM
Sample Type : WB-EDTA Report Status : Final Report
Client Address : Near Om Hospital ,New Subhash Nagar, Bhopal
HEMATOLOGY
ANTE NATEL PROFILE RAPID
Test Name Obtained Value Units Bio. Ref. Intervals Method
(Age/Gender specific)
*Blood Grouping (A B O) A Tube Agglutination
*Rh Type Positive Tube Agglutination
Method: Blood Grouping (A B O) Tube Agglutination (Foward & Reverse)
Comments:
Human red blood cells possessing A, B and D antigen will agglutinate in the presence of antibody directed towards the antigen. Agglutination of red blood cells
with Anti-A, Anti-B and Anti-D (IgM) reagent is a positive test result and indicates the presence of corresponding antigen.
All tests negative with Anti-D (IgM) reagent (Rh Negative ) are further tested for weak /partial D by Du test.
Page 4 of 8
Note: If the test results are alarming or unexpected,Client is advised to contact the laboratory immediately for possible remedial action.
Pathcare Labs Pvt. Ltd.
Regional Laboratory - H.No-105-A , Motia Talab Road,
Near Dr.Gurdeep singh eye clinic ,Opp-Tazul Masjid,
Bhopal,462001
Ph:- 07554919504
Patient Name : Mrs. PRIYA SAHU Reg. No. : 00462305050057
Age and Sex : 34 Yrs / Female PCC Code : PCL-MP-510
Referring Doctor : NA Sample Drawn Date : 05-May-2023 12:14 PM
Referring Customer : PARI COLLECTION Registration Date : 05-May-2023 01:35 PM
Vial ID : L2741442 Report Date : 05-May-2023 02:59 PM
Sample Type : WB-EDTA Report Status : Final Report
Client Address : Near Om Hospital ,New Subhash Nagar, Bhopal
HEMATOLOGY
ANTE NATEL PROFILE RAPID
Test Name Obtained Value Units Bio. Ref. Intervals Method
(Age/Gender specific)
Complete Blood Count (CBC)
Haemoglobin 9.5 g/dL 12-15 Colorimetric
RBC Count 3.3 10^12/L 3.8-4.8 Electrical Impedance
Haematocrit (HCT) 28.1 % 40-50 Calculated
MCV 84.9 fl 81-101 RBC Histogram
MCH 28.8 pg 27-32 Calculated
MCHC 33.9 g/dL 31.5-34.5 Calculated
RDW-CV 12.6 % 11.6-14.0 RBC Histogram
Platelet Count 157 10^9/L 150-410 Electrical
Impedance/Microscopy
WBC count, Total 6.3 10^9/L 4.0-10.0 Impedance
Neutrophils 67.0 % 40-70 Microscopy
Neutrophil-Absolute Count 4.2 10^9/L 2.0-7.0 Calculated
Lymphocytes 29.0 % 20-40 Microscopy
Lymphocytes-Absolute Count 1.8 10^9/L 1.0-3.0 Calculated
Monocytes 3.0 % 2-10 Microscopy
Monocytes-Absolute Count 0.2 10^9/L 0.2-1.0 Calculated
Eosinophils 1.0 % 1-6 Microscopy
Eosinophils-Absolute Count 0.1 10^9/L 0.02-0.5 Calculated
Basophils 0.0 % 0-2 Microscopy
Basophils-Absolute Count 0.0 10^9/L 0.0-0.3 Calculated
Others 0.0 % 00 Microscopy
Remarks .
Sample is Processed on Automated CBC Analyzer
Note: Haematocrit (HCT) is derived from calculated MCV based on RBC Histogram as per Manufacturer's Manual
Page 5 of 8
Note: If the test results are alarming or unexpected,Client is advised to contact the laboratory immediately for possible remedial action.
Pathcare Labs Pvt. Ltd.
Regional Laboratory - H.No-105-A , Motia Talab Road,
Near Dr.Gurdeep singh eye clinic ,Opp-Tazul Masjid,
Bhopal,462001
Ph:- 07554919504
Patient Name : Mrs. PRIYA SAHU Reg. No. : 00462305050057
Age and Sex : 34 Yrs / Female PCC Code : PCL-MP-510
Referring Doctor : NA Sample Drawn Date : 05-May-2023 12:14 PM
Referring Customer : PARI COLLECTION Registration Date : 05-May-2023 01:35 PM
Vial ID : L2741440 Report Date : 05-May-2023 02:45 PM
Sample Type : Serum Report Status : Final Report
Client Address : Near Om Hospital ,New Subhash Nagar, Bhopal
IMMUNOLOGY AND SEROLOGY
ANTE NATEL PROFILE RAPID
Test Name Obtained Value Units Bio. Ref. Intervals Method
(Age/Gender specific)
*Hepatitis B Surface Negative Negative Immunochromatography
Antigen(Rapid)
Comments:
HBsAg(Rapid)Test is an in-vitro immunochromatographic one step assay designed for qualitative determination of HBsAg in human serum or plasma.
Sensitivity: This test can detect 1.0 ng/mL of HBsAg in human serum or plasma.
Specimen found to be reactive by the above screening test must be confirmed by standard supplemental assay like ELISA, Neutralization test or PCR.
False positive results can be obtained due to the presence of other antigens or elevated levels of RF factor. This occurs in less than 1% of the samples tested.
Disclaimer: This test is only a screening method for detection of (Hepatitis B Surface Antigen (HBsAg). Further confirmation by more sensitive and
specific methods like ELISA/ CLIA and or molecular testing by PCR recommended.
HIV 1 & 2 Antibody Rapid (Chromatography) - Serum
HIV - 1 - Rapid Non Reactive Non Reactive Immunochromatography
HIV - 2 - Rapid Non Reactive Non Reactive Immunochromatography
Comments:
HIV 1 & 2 Antibodies is a rapid screening test for the qualitative detection of antibodies to HIV-1 & HIV-2 in Human serum/Plasma.
Samples found to be reactive by the above screening test will be confirmed by two other different methods as per NACO Guidelines.
HIV-1 and HIV-2 viruses share many morphological and biological characteristics. It is likely that due to this, their antibodies have a cross reactivity of 30-70%.
Appearance of dots for HIV-1 and HIV-2 antibodies on the test device does not necessarily imply co-infection from HIV-1 & HIV-2
Some samples show cross reactivity for HIV antibodies. Following factors are found to cause false positive HIV antibody test results: Naturally occurring
antibodies, Passive immunization, Leprosy, Renal Disorders, Tuberculosis, Mycobacterium avium, Herpes simplex, Hypergammaglobulinemia, Malignant
neoplasms, Rheumatoid Arthritis, Tetanus vaccination, Autoimmune diseases, Blood Transfusion, Multiple Myeloma, Haemophelia, heat treated specimens,
Lipemic serum, Anti-Auclear Antibodies, T-cell Leukocyte antigen antibodies, Epstein Barr Virus, HLA antibodies and other retroviruses
This is only a screening test. All samples detected reactive must be confirmed by using HIV Western Blot. Therefore, for a definitive diagnosis, the patient’s
clinical history, symptomatology as well as serological data, should be considered. The results should be reported only after complying with above procedure.
Disclaimer: This test is only a screening method for detection of (HIV 1 & 2 Antibody). Further confirmation by more sensitive and specific methods like
ELISA/ CLIA and or molecular testing by PCR is recommended.
Page 6 of 8
Note: If the test results are alarming or unexpected,Client is advised to contact the laboratory immediately for possible remedial action.
Pathcare Labs Pvt. Ltd.
Regional Laboratory - H.No-105-A , Motia Talab Road,
Near Dr.Gurdeep singh eye clinic ,Opp-Tazul Masjid,
Bhopal,462001
Ph:- 07554919504
Patient Name : Mrs. PRIYA SAHU Reg. No. : 00462305050057
Age and Sex : 34 Yrs / Female PCC Code : PCL-MP-510
Referring Doctor : NA Sample Drawn Date : 05-May-2023 12:14 PM
Referring Customer : PARI COLLECTION Registration Date : 05-May-2023 01:35 PM
Vial ID : L2741440 Report Date : 05-May-2023 02:45 PM
Sample Type : Serum Report Status : Final Report
Client Address : Near Om Hospital ,New Subhash Nagar, Bhopal
IMMUNOLOGY AND SEROLOGY
ANTE NATEL PROFILE RAPID
Test Name Obtained Value Units Bio. Ref. Intervals Method
(Age/Gender specific)
*Rubella Virus IgG Antibody 17.351 IU/mL <5.0 : Negative CLIA
5-10: Equivocal
>10: Positive
Comments:
The Chemiluminescent Immunoassay(CLIA) is for qualitative determination of IgG-class antibodies to Rubella in human serum.
Rubella (German or 3-day Measles) is a member of the Togavirus family and humans remain the only natural host for this virus.
This assay is used for qualitative determination of IgG-class antibodies to Rubella virus in human serum.
Primary in utero rubella infections can lead to severe sequelae for the fetus, particularly if infection occurs within the first 4 months of gestation. Congenital
Rubella Syndrome is often associated with hearing loss, cardiovascular and ocular defects.
Serum samples drawn early during acute phase of infection may be negative for IgG-class antibodies to this virus.
The presence of anti-rubella-IgG antibodies does not exclude the possibility of a recent or ongoing infection. Testing for IgM-class antibodies to Rubella should
be performed and if required Rubella avidity should be tested for IgG antibodies.
The border-line samples should be tested with fresh sample preferably after 2 -4 weeks for determining correct status of patient.
The serum sample obtained during the acute phase of infection, when only IgM antibodies are present, may be negative by this test.
*Rubella Virus IgM Antibody 1.554 AU/ml <5.0 : Negative CLIA
5-10: Equivocal
>10: Positive
Comments:
The Chemiluminescent Immunoassay(CLIA) is for qualitative determination of IgM-class antibodies to Rubella in human serum.
Rubella (German or 3-day Measles) is a member of the Togavirus family and humans remain the only natural host for this virus.
This assay is used for qualitative determination of IgM-class antibodies to Rubella virus in human serum.
Primary in utero rubella infections can lead to severe sequelae for the fetus, particularly if infection occurs within the first 4 months of gestation. Congenital
Rubella Syndrome is often associated with hearing loss, cardiovascular and ocular defects.
In recent infections detection of specific IgM antibodies in a serum sample collected within the first few days after rash onset can provide evidence of a current or
recent rubella virus infection.
However, these antibodies may persist for longer period along with appearance of IgG antibodies therefore it is important to distinguish IgM reactivity caused by
primary infection from that caused by IgM persistence or cross-reactivity with other antigens.
The border-line samples should be retested with a fresh sample.
The specimen collected earlier than 5 days after onset of symptoms may not contain sufficient IgM antibody to be positive in the test.
The test results must be interpreted in conjunction with the patient clinical information and other laboratory results.
Page 7 of 8
Note: If the test results are alarming or unexpected,Client is advised to contact the laboratory immediately for possible remedial action.
Pathcare Labs Pvt. Ltd.
Regional Laboratory - H.No-105-A , Motia Talab Road,
Near Dr.Gurdeep singh eye clinic ,Opp-Tazul Masjid,
Bhopal,462001
Ph:- 07554919504
Patient Name : Mrs. PRIYA SAHU Reg. No. : 00462305050057
Age and Sex : 34 Yrs / Female PCC Code : PCL-MP-510
Referring Doctor : NA Sample Drawn Date : 05-May-2023 12:14 PM
Referring Customer : PARI COLLECTION Registration Date : 05-May-2023 01:35 PM
Vial ID : L2741440 Report Date : 05-May-2023 02:45 PM
Sample Type : Serum Report Status : Final Report
Client Address : Near Om Hospital ,New Subhash Nagar, Bhopal
IMMUNOLOGY AND SEROLOGY
ANTE NATEL PROFILE RAPID
Test Name Obtained Value Units Bio. Ref. Intervals Method
(Age/Gender specific)
*VDRL- Syphilis Antibodies Nonreactive - Nonreactive Flocculation
Note : 1:8 and above : Significant
Comments:
VDRL test is a screening test for qualitative and semi quantitative reagin antibodies in serum or plasma.
Biological false positives are known to occur with VDRL tests when the patients have infections other than syphilis.
All patients with Reactive result should be confirmed with confirmatory tests like TPHA/FTA Antibodies.
VDRL test is also used to monitor response to treatment of syphilis.
Reagin antibodies are seen in all stages of syphilis with ranging percentages.
When making an interpretation, it is strongly advised to take all clinical data into consideration.
Correlate Clinically. Result rechecked and verified for abnormal cases.
*** End Of Report ***
Page 8 of 8
Note: If the test results are alarming or unexpected,Client is advised to contact the laboratory immediately for possible remedial action.
